Skip to content

A randomised controlled study of pregabalin in combination with duloxetine in the treatment of postherpetic neuralgia

A randomized controlled study of pregabalin in combination with duloxetine in the treatment of herpes zoster neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095909
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

Experimental group:Pregabalin and Duloxetine
Control subjects:pregabalin

Sponsors

Affiliated Hospital of Shandong Second Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. History of herpes zoster; 2. Pain numerical rating scale (NRS) score >= 4; 3. Age > 18 years old; 4. Can cooperate with the completion of pain, sleep quality and other scales assessment.

Exclusion criteria

Exclusion criteria: 1.Combined with heart, brain, liver, kidney and other systems of serious primary diseases and critical condition is difficult to tolerate treatment; 2.Combined with serious mental and psychological disorders can not cooperate; 3.Coagulation dysfunction; 4.Allergic to therapeutic drugs; 5 Affected parts of the nerves have been neurodestructive surgery.

Design outcomes

Primary

MeasureTime frame
Numerical rating scale, NRS;Adverse effects;

Secondary

MeasureTime frame
Neuropathic pain symptom inventory, NPSI;Mechanical allodynia;Mechanical Pain Threshold, MPT;Hospital Anxiety and Depression Scale, HADS;The Short-From-36 Health Survey, SF-36;

Countries

China

Contacts

Public ContactRen Zhanjie

Affiliated Hospital of Shandong Second Medical University

renzhanjie@sdsmu.edu.cn+86 135 1638 5010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026